PaperComparative pharmacology of low molecular weight heparins : Implications of manufacturing processes on biological effects
References (13)
- et al.
What is the best plasmatic activity which is correlated with the antithrombotic effect of heparin and a low molecular weight heparin fragment?
Thromb. Res.
(1987) - et al.
Heparin and low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis
Thromb.Res.
(1983) A sensitive model of venous thrombosis in rats
Thromb. Res.
(1986)- et al.
Is there an optimal therapeutical range for LMWH
- et al.
A comparison between low molecular weight heparin (Kabi 2165) and standard heparin in the intravenous treatment of deep venous thrombosis
Thromb.Haemost.
(1985) - et al.
Experimental venous thrombosis in rats treated with heparin and a low molecular weight heparin fragment
Haemostasis.
(1983)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1989 Published by Elsevier Ireland Ltd.